This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Recurrent Herpes Simplex Labialis
and you are
over 18
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

Demonstrate the safety and efficacy of NB-001 in subjects with recurrent herpes labialis (RHL).

Provided treatments

  • Drug: Vehicle versus NB-001

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01321359. The sponsor of the trial is NanoBio Corporation and it is looking for 907 volunteers for the current phase.
Official trial title:
A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis